Get started
Author

Hang-Kai Hsu

Amplification of Distant Estrogen Response Elements Deregulates Target Genes Associated with Tamoxifen Resistance in Breast Cancer
2013 · Pei-Yin Hsu, Hang-Kai Hsu, et al. · Cancer Cell · 52
PDF
Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data
2010 · Fei Gu, Hang-Kai Hsu, et al. · BMC Systems Biology · 45
PDF
Detection of DNA Methylation by MeDIP and MBDCap Assays: An Overview of Techniques
2020 · Hang-Kai Hsu, Yu-I Weng, et al. · Methods in molecular biology · 15
Table S2 from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
Suppl Information from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
Figure S1-6 from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
Suppl Figure Legends from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
PDF
Data from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
Data from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
Figure S1-6 from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
PDF
Suppl Information from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
PDF
Suppl Figure Legends from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
Table S2 from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
2023 · Pei-Yin Hsu, Victoria Shang Wu, et al.
Abstract 4778: HP1-mediated spatiotemporal control of estrogen-responsive transcription in breast cancer cells
2015 · Pei-Yin Hsu, Hang-Kai Hsu, et al. · Cancer Research
Abstract P6-07-02: Amplified DERE-mediated epigenetic repression in ERα-mediated breast tumorigenesis
2015 · Pei-Yin Hsu, Hang-Kai Hsu, et al. · Cancer Research
Abstract 4783: Amplification of distant estrogen response elements epigenetically deregulates target genes in ERα-mediated breast tumorigenesis
2014 · PEI-YIN HSU, HANG-KAI HSU, et al. · Cancer Research
Abstract 3341: Cross-talk between PI3K/AKT and ERα signaling leads to STAT3/6-modulated epigenetic transcription in aggressive breast cancer
2014 · Hang-Kai Hsu, Pei-Yin Hsu, et al. · Cancer Research
Works count: 17
Citation count: 112
H-index: 3
I10-index: 3
Year
Topic
Type